OSNAPAO: Should we use prophylaxis topical antibiotics after intravitreal injections?

Intravitreal delivery of medications by injection through the pars plana has become a routine ophthalmic procedure since anti-VEGF medicines became commercialized. Due to the huge number of intravitreal injections every year — and this number is assumed to be increasing continuously — the complications from intravitreal injection have received more attention, especially the serious adverse complications. One of the most feared complications is endophthalmitis. According to recent studies, the incidence of endophthalmitis after intravitreal injection of anti-VEGFs has been reported to be in the range of 0.02% to 0.085%. A (Read more...)